Award
New York Medical College 11365083
Tobacco Mosaic Virus as a mucosal delivery platform for an intranasal vaccine against Pseudomonas aeruginosa
Recipient
New York Medical College
Award Amount
$204,380.00
Ceiling
$204,380.00
Awarded
July 09, 2026
Identifier
11365083
Development of a mucosal vaccine platform using Tobacco Mosaic Virus for Pseudomonas aeruginosa to combat multidrug-resistant infections, funded by NIH/NIAID.
Description
The project involves developing a mucosal vaccine platform using Tobacco Mosaic Virus for Pseudomonas aeruginosa. The project aims to create a broad-spectrum vaccine to combat MDR PA infections, including defining additional vaccine antigens and mechanisms of protection. The project duration is approximately two years, funded by the NIH/NIAID.